Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Neurology
Alzheimer's Disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
ABT-089, an investigational drug for the treatment of mild to moderate Alzheimer's Disease
Phase II - ACC-001 Vaccine treatment for mild to moderate Alzheimer's Disease, trial study
Phase III - Avandia treatment for Alzheimer's disease as a means to reduce inflammation and increase sugar uptake in the brain.
Phase IV - Alzheimer's Disease Once-a-day Patch Medication, Trial Study
Alzheimer's Disease Clinical Research Study
Alzheimer's Disease Clinical Research Study
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Mild to Moderate Alzheimer's disease
Mild to Moderate Alzheimer's disease
Study of an investigational medication for the treatment of Alzheimer's Disease
ALZHEIMER’S DISEASE RESEARCH STUDY
ARE YOU STRUGGLING WITH ALZHEIMER’S DISEASE?
For people with Alzheimer's there's no time to lose.
Global early-stage research study to evaluate an investigational medication for early-stage Alzheimer’s disease
Please take note of our Alzheimer's disease clinical research study.
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Alzheimer's Disease Study
Bay Area Research Institute is conducting a clinical research trial of an investigational intravenous medication for mild to moderate Alzheimer’s disease in people between 50 and 88 years of age.
Bay Area Research Institute is conducting a clinical research trial of an investigational study medication in improving learning and memory in people with Alzheimer’s Disease.
Study of an investigational medication for the treatment of Alzheimer's Disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Alzheimer's Disease - Memory Loss
Alzheimer's Disease - Memory Loss
Study of an investigational medication for the treatment of Alzheimer's Disease
Cholesterol lowering agents to slow progression of Alzheimer's disease (CLASP study)
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Study of an investigational medication for the treatment of Alzheimer's Disease
Alzheimer’s Disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Alzheimers? Be a Part of Research.
JOIN THE FIGHT AGAINST ALZHEIMER’S DISEASE
Research study of a currently marketed medication for Alzheimer’s Disease.
Research study of an investigational medication for Alzheimer’s Disease.
Research study of an investigational medication for those who are at risk to develop Alzheimer’s Disease.
Evaluation of a investigational oral medication for patients with Alzheimer’s Disease.
New Investigational Medication for Alzheimer’s disease
New treatment aimed at slowing down the progression of Alzheimer’s disease
Alzheimer’s? Questions about treatment options?
Alzheimer's Disease Research
Clinical Research for Alzheimer's Disease
Do you know or care for someone currently taking Aricept® for alzheimer's?
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
If you or someone you know is experiencing memory loss, they may qualify for a clinical research study currently being conducted by Radiant Research.
Research for Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Stand up to Alzheimer’s Disease!
The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) in Patients with Mild to Moderate Alzheimer's Disease who are Apolipoprotein E 4 Non-Carriers
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer's Disease Clinical Study
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Clinical trial to assess the safety and tolerability of multiple oral doses of an investigational drug in elderly subjects with mild or moderate Alzheimer's disease on a stable dose of 10mg of Aricept daily.
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer's study.
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Alzheimer's Disease
Alzheimer's Disease Research for Agitation and Aggresion
Alzheimer's study
St. Petersburg, FL - Alzheimer''s Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Do you have a loved one with Alzheimer's Disease?
Do you have mild to moderate Alzeimer's Disease?
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer's Disease Research
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Phase 3 trial evaluating Treatment with intravenous Bapineuzumab vs. Placebo for Alzheimer's disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Randomized, Double blind, placebo controlled, parallel group, efficacy and safety trial of bapineuzumab in patients with mild to moderate Alzheimer's disease
Alzheimer's Fades Memories
To explore new ways of slowing the disease progression, we need your help.
The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
Late-Onset Alzheimer's Disease Family Study
Alzheimer’s Disease
Are you facing Alzheimer’s?
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A study to determine the effectiveness of an investigational medication in the treatment of Alzheimer's Disease.
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Are you or someone you know between the ages of 50 and 89 years of age with a diagnosis of mild to moderate Alzheimer's Disease?
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Dementia Prevention Study for Healthy Women
Alzheimer's disease study for mild to moderate AD.
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A 54-week, double-blind, randomized, placebo-controlled, parallel-group study to investigate the effects of rosiglitazone (extended release tablets) as adjunctive therapy to the acetylcholinesterase inhibitor (donepezil) on cognition and overall clinical response in APOE e4-stratified subjects with mild to moderate Alzheimer’s disease (REFLECT-2)
Double-Blind, Parallel-Group Comparison of 23 mg Donepezil Sustained Release to 10 mg Donepezil Immediate Release in Patients with Moderate to Severe Alzheimer’s Disease
OfficialTitle = Double-Blind, Parallel-Group Comparison of 23 mg Donepezil Sustained Release to 10 mg Donepezil Immediate Release in Patients with Moderate to Severe Alzheimer’s Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Parker Jewish Institute for Health Care & Rehabilitation Seeks Study Volunteers with Alzheimer's Disease
Dementia Prevention Study for Healthy Women
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Do you or someone you care for have Alzheimer's Disease?
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Have you or someone you love been diagnosed with Alzheimer’s Disease?
Is Alzheimer’s Disease affecting your loved one?
ALZHEIMER'S DISEASE: Don't let those memories fade…
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer's Disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer's Research Study for People taking Aricept.
Memory Loss Research Study
Research Study for Agitation and Aggression Associated with Alzheimer’s Disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
ALZHEIMER’S DISEASE
BEHAVIOR & PERSONALITY CHANGES IN ALZHEIMER’S DISEASE
INVESTIGATIONAL MEDICINE FOR ALZHEIMER’S DISEASE
SUFFERING FROM ALZHEIMER’S DISEASE?
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
Alzheimer’s Disease Research
Alzheimer’s Research Study
Alzheimer's Disease Research
Alzheimer's Reseach Study
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Have you or someone you love been diagnosed with Alzheimer's Disease?
Moderate to Severe Alzheimer’s
A clinical research trial evaluating an investigational drug for people with Alzheimer’s.
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Single Dose Study of R1450 in Patients With Alzheimer Disease.
A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
A Single Dose Study of R1450 in Patients With Alzheimer Disease.
A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Single Dose Study of R1450 in Patients With Alzheimer Disease.
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
